How Brexit transformed the UK health care workforce - healthcare-in-europe.com

Brexit, Liz Truss’s mini-budget and other “shocks” over the last 10 years have led to a serious and lasting deterioration in the UK population’s mental health, research has found. Russia’s invasion of Ukraine and the first and second Covid lockdowns also triggered big rises in psychological distress, as measured by the number of people with depression and anxiety. The findings come as Prof Peter Fonagy prepares to publish the report of his long-waited government-commissioned inquiry into the dramatic increases in recent years in diagnoses of mental illness, ADHD and autism. It will be published on Friday amid concern that those conditions help explain why a record 2.8 million Britons are too sick to work and almost 1 million young people aged 16 to 24 have become “Neets” – not in education, employment or training. Researchers led by Dr Annie Jeffery of University College London used data from the UK Household Longitudinal Study of 87,857 people aged 16 and older, which was collected every year between 2009 and 2024, to estimate the mental health impact of those five “systemic shocks”.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.